Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling-Reference-Cited by-同舟云学术

Assessment of urinary pharmacokinetics and pharmacodynamics of orbifloxacin in healthy dogs with ex vivo modelling

Published:2017-05-01 Issue:5 Volume:66 Page:616-621
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Shimizu Takae¹²,Harada Kazuki¹²,Manabe Saki²,Tsukamoto Taku³,Ito Norihiko²,Hikasa Yoshiaki¹²

Affiliation:

1. The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1, Yoshida, Yamaguchi 753-8511, Japan

2. Joint Department of Veterinary Medicine, Tottori University, Minami 4-101, Koyama-Cho, Tottori 680-8553, Japan

3. Global Application Development Center Analytical & Measuring Instruments Division, Shimadzu Corporation, 1 Nishinokyo, Kuwahara-cho, Nakagyo-ku, Kyoto 604-8511, Japan

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference25 articles.

1. Canine bacterial urinary tract infections: New developments in old pathogens

2. Interrelations of organism prevalence, specimen collection method, and host age, sex, and breed among 8,354 canine urinary tract infections (1969–1995);Ling;J Vet Intern Med,2001

3. UTIs in Small Animal Patients: Part 1: Etiology and Pathogenesis

4. Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases

5. Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?;Pharmaceutics;2023-04-07

2. A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against Escherichia coli;Frontiers in Pharmacology;2022-09-15

3. Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward;Journal of Veterinary Pharmacology and Therapeutics;2022-07-30

4. Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study;Antibiotics;2020-05-05

5. Assessment of urinary pharmacokinetic and pharmacodynamic profiles of faropenem against extended-spectrum β-lactamase-producing Escherichia coli with canine ex vivo modelling: a pilot study;Access Microbiology;2019-03-01